Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Lymphoma, Non-Hodgkin 29Hodgkin Disease 28Myelodysplastic Syndromes 27Leukemia, Myeloid, Acute 26Leukemia, Lymphocytic, Chronic, B-Cell 25Lymphoma 24Leukemia 22Lymphoma, Mantle-Cell 18Graft vs Host Disease 18Multiple Myeloma 17Lymphoma, Large B-Cell, Diffuse 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Myeloproliferative Disorders 14Lymphoma, Follicular 14Burkitt Lymphoma 14Waldenstrom Macroglobulinemia 13Lymphoma, B-Cell, Marginal Zone 13Primary Myelofibrosis 11Leukemia, Myelomonocytic, Chronic 10Blast Crisis 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasms, Plasma Cell 8Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Myeloid, Accelerated Phase 8Neoplasms 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, T-Cell, Cutaneous 7Leukemia, Prolymphocytic 7

Interventions

blinatumomab 16Cyclophosphamide 15fludarabine phosphate 8fludarabine 8Methotrexate 7Cytarabine 7Rituximab 6Vincristine 5Mercaptopurine 5Melphalan 4Daunorubicin 4obinutuzumab 3Whole-Body Irradiation 3Immunotherapy, Adoptive 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Doxorubicin 3Dexamethasone 3Asparaginase 3tisagenlecleucel 2thymoglobulin 2pegaspargase 2Vindesine 2Thioguanine 2Teniposide 2Stem Cell Transplantation 2Radiotherapy 2Prednisone 2Prednisolone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm, Residual × Sirolimus × Lymphoid × Clear all
NCT03192397 2026-04-14

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Roswell Park Cancer Institute

Phase 1/2 Active not recruiting
35 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡